News & Analysis on Clinical Trial Services & Contract Research And Development
Pfizer will pay an out of court settlement to resolve a long-running case alleging that it carried out an illegal trial of its meningitis drug Trovan (trovafloxacin) in Nigeria that resulted in the death of 11 children.
OctoPlus has inked a deal with a European biotech that will see it evaluate the feasibility of a controlled release formulation using its proprietary drug delivery technology.
ReSearch Pharmaceutical Services has expanded its activities into the Asian market via the purchase of Chinese contract research organisation (CRO) Paramax International.
Piramal Healthcare is switching its UK API making operations to Morpeth, Nothumberland after a downturn in the Indian CMO’s international business cut capacity utilisation at its former base in Huddersfield to just 35 per cent.
United Drug’s contract packaging business is expected to report a significant dip in profits but strong performance in the sales division helped push up its share price.
Contract research organisation PPD has boosted its compound partnering programme with the purchase of dermatology specialist Magen BioSciences, and divested its presclinical research subsidiary Pedmont Research Centre.
Novozymes and Millipore have launched an animal-free culture supplement, which has been designed to reduce risk and regulatory pressures in upstream biopharmaceutical processes.
The use of intelligent sorbents to improve product stability can save companies six to 12 months of development and boost revenues, according to Adrian Possumato, global director at Multisorb.